Index · Artikel · India generic drugmakers' woes put new focus on quality over price

India generic drugmakers' woes put new focus on quality over price

2014-03-25 1
   
Advertisement
résumén">A spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say. In the short
Advertisement

India generic drugmakers' woes put new focus on quality over price


n">A spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.

In the short term, that is expected to benefit larger global competitors, such as Teva Pharmaceutical Industries Ltd, Actavis Plc and Mylan Inc, which will be called upon to supply drugs no longer available from some of their rivals in India, they said.

Over the longer term, the trend will put a new premium on manufacturers who can demonstrate a strong quality record over time and limit supply disruptions, particularly as U.S. drugstore chains and pharmaceutical wholesalers make deals that consolidate their buying on a larger scale than ever.

"When you talk to companies they will tell you that this was an industry that used to be about nothing but price. Now the ability to supply the market and have a reliable supply, to be in good favor with the FDA, that's starting to mean something to customers," said Gabelli & Co analyst Kevin Kendra.

The biggest setback for India's $14 billion a year generic drug industry came in January, when the FDA banned imports from all the Indian plants of Ranbaxy Laboratories Ltd, India's No. 1 drugmaker by sales, over repeated production quality lapses.

While generic drugmakers based in the United States and elsewhere have also been cited by the U.S. Food and Drug Administration for quality control problems over the years, India's industry has come under fresh scrutiny recently as the agency steps up its inspections there.

On a smaller scale, the U.S. health regulator banned medicines made at a Sun Pharmaceutical Industries Ltd plant at Karkhadi.

Sun has said that plant accounts for less than 1 percent of its sales.

Wockhardt Ltd and Dr Reddy's Laboratories Ltd have also run afoul of the FDA or been involved in recent major product recalls.

Some U.S. doctors say the headlines have raised new concerns about the quality of the generic drug supply.

Pharmacy chains including CVS Caremark Corp and Walgreen Co would not comment on whether they have altered their purchasing operations in any way.

Pharmacy benefits manager Express Scripts Holding Co, one of the largest purchasers of generic drugs, would not single out India, but said it has taken notice of quality concerns on a company-by-company basis.

"We have increased our surveillance throughout the supply chain," said Express Scripts spokesman Brian Henry.

SHORT-TERM BENEFICIARIES

When products are temporarily removed from the U.S. market, "that has given some larger manufacturers the ability to take up pricing and pick up some share," said RBC Capital Markets analyst Randall Stanicky.

Jason Kolbert, an analyst with Maxim Group, sees Teva, with its vast geographic reach and huge product portfolio, as a "direct beneficiary" of Indian drug company setbacks. It sells, for example, a version of the antibiotics made at the Sun plant under FDA sanctions.

"These companies have to spend six months or a year fixing a manufacturing quality control problem, so Teva is likely to pick up a little bit of growth because this is not their problem," Kolbert said.

Morningstar analyst Michael Waterhouse said purchasers would likely make a distinction between Ranbaxy, which has repeatedly been cited by the FDA for lapses, against its Indian peers that have had more sporadic problems, not unlike companies elsewhere around the globe.

"The FDA overall is trying to raise the bar because it's a brutal industry for a lot of these companies where the pricing pressure is so hefty," he said.

Wockhardt, Ranbaxy and Dr. Reddy's did not respond to requests for comment.

Piyush Nahar, an analyst with Jefferies India Private Ltd, said Indian drugmakers have increased their investment in compliance and some are considering investing in U.S. or European plants to overcome regulatory challenges.

Waterhouse expects those efforts to pay off.

"Ultimately you would think standards would be raised in India and they would still remain a formidable opponent," he said.

(Reporting by Bill Berkrot in New York, additional reporting by Zeba Siddiqui in Bangalore; editing by Michele Gershberg and G Crosse)

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated

  • Funktioniert das wirklich evern w / o Übung Ich bin neuer Start 2DAY I 270 gewichten wollen von November 80 zu verlieren?

    Ich beginne Phentramine heute 19. Februar i bei 270 bin möchte 80 lbs von November zu verlieren Aller Anfang ist so hart Motivation brauchen ----schneiden---- In Antwort auf 2010-02-19 11:19 Uhr in twhumphr Dieses Medikament kann Ihnen die Motivation
  • QED verdient Inc. 500 Anerkennung für schnelles Wachstum

    QED verdient Inc. 500 Anerkennung für schnelles Wachstum
    QED Präsident Hiroyuki Fujita und CWRU Präsident Barbara R. Snyder Die Auszeichnungen weiterhin für Qualität Elektrodynamik, die Designer und Hersteller von fortschrittlichen Spulen und Elektronik für die Magnetresonanztomographie (MRT), besser bekan
  • Wie man eine Injektion in die Knie durchführen

    Wie man eine Injektion in die Knie durchführen
    Sie können eine Injektion in die Knie müssen entweder im Falle eines Erguss zu entfernen Schwellungen oder Medikamente wie Synvisc zu setzen oder in die Knie Kortison. Wie wird eine Injektion durchgeführt? Wie ein Knie Injection is Done Bestimmen Sie
  • Stevens-Johnson-Syndrom

    Stevens-Johnson-Syndrom
    Stevens-Johnson-Syndrom (SJS) wird in der Regel als eine schwere Form von Erythema multiforme gedacht, die selbst eine Art von Überempfindlichkeitsreaktion auf ein Medikament, einschließlich Over-the-counter Medikamente oder eine Infektion, wie Herpe
  • H7N9 Vogelgrippe-Arzneimittelresistenz entwickeln Mai

    H7N9 Vogelgrippe-Arzneimittelresistenz entwickeln Mai
    Diese Centers for Disease Control (CDC) Wissenschaftler misst die Menge des H7N9-Virus, das in CDC Labor gezüchtet und geerntet wurde. Credit: CDC / Douglas E. Jordan Einige Stämme des H7N9-Vogelgrippe in China werden immer resistent gegen die einzig
  • 4 Arten der Kommunikation: Identifizieren Sie Ihr jugendlich Stil

    4 Arten der Kommunikation: Identifizieren Sie Ihr jugendlich Stil
    Die heutigen digitalen Zeitalter bedeutet Jugendliche kommunizieren anders als Generationen in der Vergangenheit. Statt ein privates Gespräch mit jemandem haben, sind sie oft machen öffentliche Ankündigungen über Social Media. Als Folge müssen viele
  • FDA seeks to damp criticism over mobile health app proposals

    FDA seeks to damp criticism over mobile health app proposals
    n">The U.S. Food and Drug Administration said its plans for regulating certain healthcare apps used on smartphones and tablets will not impose undue burdens on developers or stifle the growing mobile health industry. Christy Foreman, director of t
  • Hier ist, was die FDA ist und nicht während der Regierung Abschaltung tun

    Hier ist, was die FDA ist und nicht während der Regierung Abschaltung tun
    Es gibt viele Spekulationen darüber, was die Regierung Herunterfahren bedeutet für die US Food and Drug Administration - einschließlich der verschiedenen Berichte , die unsere Nahrung nicht geprüft zu werden . Etwas mehr als die Hälfte der Mitarbeite
  • Gildess FE 1/20, habe keine Zeit in 2 Monaten hatte?

    Ich begann Geburtenkontrolle unter (Gildess FE) Dezember 2012, als ich 18 drehte Dieses Medikament stark die Strömung meiner Perioden reduziert hat und hat sie völlig schmerzlos gemacht hat das einzige Problem, überhaupt die Tatsache, dass ich noch n
  • Was ist der Isthmus?

    Was ist der Isthmus?
    Die meisten Menschen haben eine harte Zeit, Isthmus Aussprechen, geschweige denn sagen Sie die Definition. Vielleicht wissen Sie , dass ein schmaler Streifen Land , umgeben von Wasser , die zwei Stücke von größeren Land verbindet , wird als Isthmus b